Expression of CYP2A genes in human liver and extrahepatic tissues

被引:135
作者
Koskela, S
Hakkola, J
Hukkanen, J
Pelkonen, O
Sorri, M
Saranen, A
Anttila, S
Fernandez-Salguero, P
Gonzalez, F
Raunio, H [1 ]
机构
[1] Univ Oulu, Dept Pharmacol & Toxicol, FIN-90220 Oulu, Finland
[2] Univ Oulu, Dept Otolaryngol, FIN-90220 Oulu, Finland
[3] Finnish Inst Occupat Hlth, Helsinki, Finland
[4] NCI, Mol Carcinogenesis Lab, Bethesda, MD 20892 USA
基金
芬兰科学院;
关键词
cytochrome P450 gene expression; CYP2A; nasal mucosa; liver; extrahepatic tissues; xenobiotic metabolism;
D O I
10.1016/S0006-2952(99)00015-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Members of the human cytochrome P450 ZA (CYP2A) subfamily are known to metabolize several promutagens, procarcinogens, and pharmaceuticals. In this study, the expression of the three genes found in the human CYP2A gene cluster was investigated in the liver and several extrahepatic tissues by gene-specific reverse transcriptase polymerase chain reaction (RT-PCR). All three transcripts (CYP2A6, CYP2A7, and CYP2A13) were found to be present in liver, Quantitative RT-PCR analysis showed that CYP2A6 and CYP2A7 mRNAs were present at roughly equal levels in the liver, while CYP2A13 was expressed at very low levels. Two putative splicing variants of CYP2A7 were found in the liver. Nasal mucosa contained a low level of CYP2A6 and a relatively high level of CYP2A13 transcripts. Kidney, duodenum, lung, alveolar macrophages, peripheral lymphocytes, placenta, and uterine endometrium were negative for all transcripts. This survey gives a comprehensive picture of the expression pattern of CYP2A genes in liver and extrahepatic tissues and constitutes a basis for a search for functional CYP2A forms and their roles in chemical toxicity in liver and nasal mucosa. (C) 1999 Elsevier Science Inc.
引用
收藏
页码:1407 / 1413
页数:7
相关论文
共 42 条
[1]   5 OF 12 FORMS OF VACCINIA VIRUS-EXPRESSED HUMAN HEPATIC CYTOCHROME-P450 METABOLICALLY ACTIVATE AFLATOXIN-B1 [J].
AOYAMA, T ;
YAMANO, S ;
GUZELIAN, PS ;
GELBOIN, HV ;
GONZALEZ, FJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (12) :4790-4793
[2]   CYTOCHROME-P450 2A OF NASAL EPITHELIUM - REGULATION AND ROLE IN CARCINOGEN METABOLISM [J].
BEREZIAT, JC ;
RAFFALLI, F ;
SCHMEZER, P ;
FREI, E ;
GENESTE, O ;
LANG, MA .
MOLECULAR CARCINOGENESIS, 1995, 14 (02) :130-139
[3]   HIGH VARIABILITY OF NITROSAMINE METABOLISM AMONG INDIVIDUALS - ROLE OF CYTOCHROMES P450 2A6 AND 2E1 IN THE DEALKYLATION OF N-NITROSODIMETHYLAMINE AND N-NITROSODIETHYLAMINE IN MICE AND HUMANS [J].
CAMUS, AM ;
GENESTE, O ;
HONKAKOSKI, P ;
BEREZIAT, JC ;
HENDERSON, CJ ;
WOLF, CR ;
BARTSCH, H ;
LANG, MA .
MOLECULAR CARCINOGENESIS, 1993, 7 (04) :268-275
[4]  
Chang TKH, 1996, CYTOCHROMES P450 MET, P99
[5]   IMMUNOLOCALIZATION OF 2 CYTOCHROME-P450 ISOZYMES IN RAT NASAL CHEMOSENSORY TISSUE [J].
CHEN, Y ;
GETCHELL, ML ;
DING, XX ;
GETCHELL, TV .
NEUROREPORT, 1992, 3 (09) :749-752
[6]   HUMAN CYTOCHROME P450IIA3 - CDNA SEQUENCE, ROLE OF THE ENZYME IN THE METABOLIC-ACTIVATION OF PROMUTAGENS, COMPARISON TO NITROSAMINE ACTIVATION BY HUMAN CYTOCHROME P450IIE1 [J].
CRESPI, CL ;
PENMAN, BW ;
LEAKEY, JAE ;
ARLOTTO, MP ;
STARK, A ;
PARKINSON, A ;
TURNER, T ;
STEIMEL, DT ;
RUDO, K ;
DAVIES, RL ;
LANGENBACH, R .
CARCINOGENESIS, 1990, 11 (08) :1293-1300
[7]   EXPRESSION AND ALTERNATIVE SPLICING OF THE CYTOCHROME-P-450 CYP2A7 [J].
DING, SH ;
LAKE, BG ;
FRIEDBERG, T ;
WOLF, CR .
BIOCHEMICAL JOURNAL, 1995, 306 :161-166
[8]   HUMAN LIVER-MICROSOMES ARE EFFICIENT CATALYSTS OF 1,3-BUTADIENE OXIDATION - EVIDENCE FOR MAJOR ROLES BY CYTOCHROMES P450 2A6 AND 2E1 [J].
DUESCHER, RJ ;
ELFARRA, AA .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1994, 311 (02) :342-349
[9]   THE CYP 2A GENE SUBFAMILY - SPECIES-DIFFERENCES, REGULATION, CATALYTIC ACTIVITIES AND ROLE IN CHEMICAL CARCINOGENESIS [J].
FERNANDEZSALGUERO, P ;
GONZALEZ, FJ .
PHARMACOGENETICS, 1995, 5 :S123-S128
[10]  
FERNANDEZSALGUERO P, 1995, AM J HUM GENET, V57, P651